Efficacy and Safety of Octagam® in Patients With Chronic Inflammatory Demyelinating Polyneuropathy-Reference-Cited by-同舟云学术

Efficacy and Safety of Octagam® in Patients With Chronic Inflammatory Demyelinating Polyneuropathy

Published:2019-03-22 Issue:1 Volume:8 Page:69-78
ISSN:2193-8253
Container-title:Neurology and Therapy
language:en
Short-container-title:Neurol Ther

Author:

Belmokhtar Chafké,Lozeron Pierre,Adams David,Franques Jérôme,Lacour Arnaud,Godet Etienne,Bataille Mathieu,Dubourg Odile,Angibaud Gilles,Delmont Emilien,Bouhour Françoise,Corcia Philippe,Pouget Jean

Funder

Octapharma, France SAS

Publisher

Springer Science and Business Media LLC

Subject

Clinical Neurology,Neurology

Link

http://link.springer.com/content/pdf/10.1007/s40120-019-0132-5.pdf

Reference37 articles.

1. Said G. Chronic inflammatory demyelinating polyneuropathy. Neuromuscul Disord. 2006;16(5):293–303. https://doi.org/10.1016/j.nmd.2006.02.008 .

2. Lunn MP, Manji H, Choudhary PP, Hughes RA, Thomas PK. Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in South East England. J Neurol Neurosurg Psychiatry. 1999;66(5):677–80.

3. McLeod JG, Pollard JD, Macaskill P, Mohamed A, Spring P, Khurana V. Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales. Australia. Ann Neurol. 1999;46(6):910–3.

4. Laughlin RS, Dyck PJ, Melton LJ 3rd, Leibson C, Ransom J. Incidence and prevalence of CIDP and the association of diabetes mellitus. Neurology. 2009;73(1):39–45. https://doi.org/10.1212/WNL.0b013e3181aaea47 .

5. Mygland A, Monstad P. Chronic polyneuropathies in Vest-Agder. Norway. Eur J Neurol. 2001;8(2):157–65.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Tolerability of Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy: Results of the ProCID Study;Drug Safety;2023-06-28

2. The Choice between Intravenous and Subcutaneous Immunoglobulins: Aspects for Consideration;Pharmacology;2022

3. Immune-globulin;Reactions Weekly;2019-10